Headache Relief
- Product NDC
- 41250-334
- Requested package NDC
- 41250-334-08
- 11-digit product format
- 412500334
- Labeler code
- 41250
- Product ID
- 41250-334_746072ad-79e2-4d14-939d-d3c4396b47f2
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Aspirin, Caffeine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Meijer Distribution Inc
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2008-03-13
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250; 250; 65 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 41250-334 | 41250-334-08 | D | Discontinued by firm | 2026-11-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Headache Relief
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| ASPIRIN | 250 mg/1 |
| CAFFEINE | 65 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308297 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 04f2c3ed-4bcf-4b6a-b8fb-0aa6ecb3dca2 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41250-334-08 | Headache ReliefExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 18 | |
| 41250-334-08 | Headache ReliefExtra Strength | 24 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 24 | 18 | |
| 41250-334-12 | Headache ReliefExtra Strength | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 18 | |
| 41250-334-12 | Headache ReliefExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 18 | |
| 41250-334-15 | Headache ReliefExtra Strength | 50 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 50 | 18 | |
| 41250-334-15 | Headache ReliefExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 18 | |
| 41250-334-98 | Headache ReliefExtra Strength | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 18 | |
| 41250-334-98 | Headache ReliefExtra Strength | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 18 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41250-334 | HEADACHE RELIEF EXTRA STRENGTH (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET, FILM COATED [MEIJER DISTRIBUTION INC] | 17 | Current NDC, Legacy NDC, 8 package rows | 20241211_04f2c3ed-4bcf-4b6a-b8fb-0aa6ecb3dca2.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen Regular Strength | ACETAMINOPHEN | Aurohealth LLC | cc0ab7a1-e535-4dc8-962f-c58949fc1737 | 2023-11-29 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Aurohealth LLC | a4ff94b9-c248-4cd3-8491-38e9555cc22e | 2023-11-29 | Warnings | M013 |
| Aurophen Extra Strength for Adults | ACETAMINOPHEN | Aurohealth LLC | d59c5f04-4bcc-4a52-a42f-e049506f00de | 2023-11-29 | Warnings | M013 |
| Aurophen Extra Strength for Adults | ACETAMINOPHEN | Aurohealth LLC | a769094b-1e91-4ca7-ba67-21aa7e312910 | 2023-11-29 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Aurohealth LLC | 30756257-f748-4a5d-b031-dd267d0f91ad | 2023-11-29 | Warnings | M013 |
| Aurophen Regular Strength | ACETAMINOPHEN | Aurohealth LLC | 8eda893f-5266-4b7a-95b9-2e194973cf06 | 2023-11-29 | Warnings | M013 |
| Childrens Pain Relief | ACETAMINOPHEN | Aurohealth LLC | 00ec6518-b5e3-49d1-a342-139381c3bfd2 | 2023-11-29 | Warnings | M013 |
| CHILDRENS PAIN RELIEF | ACETAMINOPHEN | Better Living Brands, LLC | fadb4c09-071f-56c0-e053-6294a90ae6c1 | 2023-11-28 | Warnings | M013 |
| Acetaminophen and Diphenhydramine hydrochloride | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Better Living Brands, LLC | fc07d516-9ffe-9989-e053-6294a90ae1a5 | 2023-11-28 | Warnings | M013 |
| NOTTS - Tension Headache | ACETAMINOPHEN, CAFFEINE | VIVUNT PHARMA LLC | 08f2ae03-967b-ad7e-e063-6294a90a8484 | 2023-11-24 | Warnings | M013 |
| Sanatos Multi Symptoms Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Pharmadel LLC | 0a60326a-a17b-e843-e063-6394a90ac211 | 2023-11-22 | Warnings | M013 |
| Sanatos Nighttime Multi Symptoms | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Pharmadel LLC | 0ab188f3-f7f9-d665-e063-6294a90a198a | 2023-11-22 | Warnings | M013 |
| ASPIRIN | ASPIRIN | TIME CAP LABS INC | fe12519c-3e5f-4592-bd34-2d6b81b981f4 | 2023-11-22 | Warnings | M013 |
| Rugby Regular Strength Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | 400d4a29-9e39-4e74-8272-37be5d789924 | 2023-11-22 | Warnings | M013 |
| RIGHT REMEDIES Pain Relief Extra Strength Caplet | ACETAMINOPHEN | Strive Pharmaceuticals Inc. | dcce28d9-8528-489e-b995-1d98e9d0e6ad | 2023-11-21 | Warnings | M013 |
| Sanatos Multi Symptom Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCI | Pharmadel LLC | 0ab11691-5b29-55fc-e063-6394a90aa328 | 2023-11-17 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | 1e223faa-f6d0-4235-bc4c-6cfca84a5b0a | 2023-11-17 | Warnings | M013 |
| SanaTos X | ACETAMINOPHEN, DEXTROMETHORPHAN HBR,GUAIFENESIN, PHENYLEPHRINE HCI | Pharmadel LLC | 85b8ef3d-7318-7f3b-e053-2991aa0a0777 | 2023-11-14 | Warnings | M013 |
| RIGHT REMEDIES EXTRA STRENGTH PM Pain Relief | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Strive Pharmaceuticals Inc. | 8badbaad-eb35-4251-a779-00474819360d | 2023-11-13 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Trifecta Pharmaceuticals USA LLC | 09935a74-34b0-0e7c-e063-6294a90a7c83 | 2023-11-07 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | 04f2c3ed-4bcf-4b6a-b8fb-0aa6ecb3dca2 | 18 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | 04f2c3ed-4bcf-4b6a-b8fb-0aa6ecb3dca2 | 18 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | 04f2c3ed-4bcf-4b6a-b8fb-0aa6ecb3dca2 | 18 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 41250-334-08 | 41250033408 | 1 BOTTLE, PLASTIC in 1 CARTON (41250-334-08) > 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC | 2008-03-13 | 0000-00-00 | No | No | Current |